The global stem cell banking market is expected to grow from USD 5.68 billion in 2017 to USD 9.87 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 8.21%.
“Rising awareness of the therapeutic potential of stem cells
is one of the factors largely attributing to the growth of stem cell banking market globally”
The factors attributing to the growth of the market are raising awareness of the therapeutic potential of stem cells, technology development related to stem cell preservation, storage, and processing, advance hematopoietic stem cell transplantation procedures, and investment-friendly stem cell-based research. However, some factors such as limited affordability of stem cell banking, and stringent regulatory frameworks may hinder the market growth. The global stem cell banking market is expected to showcase the opportunities such as increasing demand and potential from emerging countries. In the near future, the market may face the possible challenges in the growth due to and socio-ethical concerns related to embryonic stem cells. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global stem cell banking market.
On the basis of service, the global stem cell banking market is studied across Analysis, Collection, Processing, Storage, and Transportation.
On the basis of source, the global stem cell banking market is studied across Adipose Tissue-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Dental Pulp-Derived Stem Cells, Human Embryo-Derived Stem Cells, and Placental Stem Cells.
On the basis of type, the global stem cell banking market is studied across Cord Blood and Cord Tissue.
On the basis of application, the global stem cell banking market is studied across Clinical Research and Personalized Banking.
On the basis of geography, the global stem cell banking market is studied across the Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
Access this report @ https://www.reportocean.com/industry-verticals/sample-request?report_id=21506
“Amag Pharmaceuticals, Inc.: The potential growing player for the global stem cell banking market”
The key players profiled in the global stem cell banking market are Amag Pharmaceuticals, Inc., Americord Registry LLC, China Cord Blood Corporation, Cord Blood America, Inc., Cord Blood Registry Systems, CordVida, Cordlife, Cordlife Group Limited, Cryo-Cell International, Cryo-Cell International, Inc., Cryo-Save AG, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., Global Cord Blood, LifeCell International, Lifeforce Cryobank Sciences, Inc., Smart Cells International, StemCyte, ViaCord, and Vita34.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global stem cell banking market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global stem cell banking market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global stem cell banking market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global stem cell banking market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global stem cell banking market.
Complete Report Details @ https://www.reportocean.com/industry-verticals/sample-request?report_id=21506
TABLE OF CONTENTS
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
22.214.171.124. Secondary Instrument
126.96.36.199. Primary Instrument
2.1.2. Research Approaches
188.8.131.52. Bottom-up Approach
184.108.40.206. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Vendor Ranking Analysis
4.4. Market Dynamics
220.127.116.11. Rising awareness of the therapeutic potential of stem cells
18.104.22.168. Technology development related to stem cell preservation, storage, and processing
22.214.171.124. Advance hematopoietic stem cell transplantation procedures
126.96.36.199. Investment friendly stem cell-based research
188.8.131.52. Limited affordability of stem cell banking
184.108.40.206. Stringent regulatory frameworks
220.127.116.11. Increasing demand and potential from emerging countries
18.104.22.168. Socio-ethical concerns related to embryonic stem cells
4.5. Porter’s Five Forces Analysis
4.5.1. Threat of New Entrants
4.5.2. Threat of Substitutes
4.5.3. Bargaining Power of Customers
4.5.4. Bargaining Power of Suppliers
4.5.5. Industry Rivalry
4.6. Patent Registered and Analysis
Get more information, Ask for free sample copy of this @ https://www.reportocean.com/industry-verticals/sample-request?report_id=21506
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Name: Varda
email: [email protected]